Pharmaceutical Exporter to Malaysia from India
Indian Generic Medicines (IGM) is a WHO-GMP-aligned, DGFT-registered pharmaceutical exporter to Malaysia from India — supplying generics, oncology, antibiotics, antivirals and vaccines to licensed importers, hospitals and distributors, with NPRA-ready documentation.
India to Malaysia: a reliable medicine-supply corridor
Malaysia runs a well-regulated, quality-focused healthcare system with strong public and private sectors. India’s WHO-GMP generics offer the quality and affordability Malaysian buyers expect, across a very broad product range. As a reliable pharmaceutical exporter to Malaysia from India, Indian Generic Medicines (IGM) operates within this corridor with full NPRA-ready documentation, sourcing from facilities holding WHO-GMP, US FDA and EU-GMP certifications.
Key takeaways
- Malaysia has a well-regulated, quality-focused pharmaceutical market with strong public and private sectors.
- Every product must be registered with NPRA (MAL number) and imported through a licensed importer.
- A WHO-GMP exporter provides COA, CPP, GMP certificate and Certificate of Origin; halal requirements may apply to some products.
- India–ASEAN trade ties ease pharmaceutical trade with Malaysia.
- IGM is a DGFT-registered exporter supplying generics, oncology, antibiotics, antivirals and vaccines to Malaysia.
Why Malaysia sources pharmaceuticals from India
Malaysia runs a well-regulated, quality-focused healthcare system with strong public and private sectors. India’s WHO-GMP generics offer the quality and affordability Malaysian buyers expect, across a very broad product range.
What a pharmaceutical exporter to Malaysia from India supplies
The range spans the therapeutic segments Malaysia’s hospitals, distributors and pharmacies need most:
Indian Generic Medicines: a trusted export partner for Malaysia
Buyers look for a proven track record, verifiable certifications and reliable supply. IGM delivers all three:
What Malaysia requires from Indian exporters
Malaysia’s medicines are regulated by the National Pharmaceutical Regulatory Agency (NPRA) and the Drug Control Authority (DCA) under the Ministry of Health. Every product must be registered (receiving an MAL registration number) and imported through a licensed importer. WHO-GMP is expected from the foreign manufacturer; halal requirements may apply to certain products, which IGM can coordinate with manufacturing partners.
| Requirement / Document | Purpose |
|---|---|
| NPRA product registration | Required before a medicine can be marketed in Malaysia. |
| Importer licence & import permit | Held by the Malaysia partner to legally import and distribute. |
| Certificate of Analysis (COA) | Confirms quality and composition of each batch. |
| Certificate of Pharmaceutical Product (CPP) | Confirms the product’s regulatory status in India (WHO format). |
| GMP Certificate | Confirms the site meets Good Manufacturing Practice standards. |
| Certificate of Origin & commercial invoice | Required for customs clearance. |
In practice, the Malaysia importer or distributor — not the Indian exporter — holds the NPRA licence and manages registration. IGM works closely with licensed local partners and provides all supplier-side documentation.
How to import medicine from India to Malaysia — step by step
Who in Malaysia should work with an Indian exporter
Source certified medicines from India for Malaysia
Request a product catalogue, price and quotation. Share your therapeutic list, quantities and registration status — we’ll respond with NPRA-ready documentation and logistics options.
Frequently asked questions
The National Pharmaceutical Regulatory Agency (NPRA) and the Drug Control Authority (DCA), under the Ministry of Health. Products must be registered (MAL number) and imported through a licensed importer.
The Malaysian importer must be licensed and hold NPRA product registration (MAL number). The Indian exporter provides DGFT registration, Pharmexcil RCMC, WHO-GMP sourcing, COA, CPP, GMP certificate and Certificate of Origin.
Halal certification may apply to certain products, though it is not mandatory for all medicines. IGM can coordinate with manufacturing partners where halal documentation is needed.
India’s WHO-GMP generics deliver the quality and affordability Malaysian buyers expect, across a broad range of therapeutic categories.
By sea to Port Klang or Penang, roughly 2–3 weeks, or by air to KLIA, about 4–5 days. Cold-chain products ship temperature-monitored.
COA, CPP, GMP certificate, Certificate of Origin, commercial invoice and packing list. NPRA registration is handled by the Malaysian importer using this documentation.
Your trusted medicine exporter from India to Malaysia
As a DGFT-registered pharmaceutical exporter to Malaysia from India, IGM supplies WHO-GMP-aligned generics, oncology drugs, antibiotics, antivirals, vaccines and injectables — each order backed by NPRA-compatible documentation and reliable logistics. Combining India’s certified manufacturing quality with a broad product range and dependable supply, IGM is built to serve importers, hospitals and distributors across Malaysia.
